Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot pharmacokinetic study of beta-lactam antibiotics in blood and sputum of cystic fibrosis patients
2016-000398-19Phase 4Terminated
- Sponsor
- Ghent University
- Start
- Feb 2016
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of piperacillin + tazobactam, ceftazidime and meropenem in cystic fibrosis (CF) and bacterial disease (3 arms), sponsored by Ghent University. Started Feb 2016; status: terminated.
02
Drugs
piperacillin + tazobactamceftazidimemeropenem
03
Conditions
cystic fibrosis (CF)bacterial disease
Beyond the preview
Go deeper on 2016-000398-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000398-19.